Healthcare shares were nearly flat.
AstraZeneca's coronavirus antibody treatment failed in late-stage clinical trials to achieve its primary goal of preventing symptomatic Covid-19 in people recently exposed to the virus, the latest disappointment in a broader search for reliable post-infection therapies.
Meanwhile, a national charity will for the first time buy medical debt, totaling $278 million, directly from hospitals, a push to speed financial relief to patients, many of whom shouldn't have been billed at all under the hospitals' financial-aid policies.
RIP Medical Debt, which uses donations to wipe out unpaid medical bills, has reached a deal with nonprofit Ballad Health, a dominant hospital system in Tennessee and Virginia, to buy debt owed by 82,000 low-income patients.
Write to Amy Pessetto at email@example.com
(END) Dow Jones Newswires
June 15, 2021 17:09 ET (21:09 GMT)Copyright (c) 2021 Dow Jones & Company, Inc.